Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2–high atopic dermatitis disease endotype

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 4, 2018, Pages 1298-1309

  Dyjack, Nathan ^a   Goleva, Elena ^a   Rios, Cydney ^a   Kim, Byung Eui ^a   Bin, Lianghua ^a   Taylor, Patricia ^a   Bronchick, Caroline ^a   Hall, Clifton F ^a   Richers, Brittany N ^a   Seibold, Max A ^a,b   Leung, Donald Y M ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

atopic dermatitis; inflammation; RNA sequencing; Skin; type 2 immune response

Indexed keywords

CHEMOKINE RECEPTOR CCR4; FC EPSILON RI PROTEIN; INTERLEUKIN 13; MACROPHAGE DERIVED CHEMOKINE; PROTEIN; RNA; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; EPIDERMIS CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IL4R GENE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPHOCYTE ACTIVATION; MALE; MINIMALLY INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SKIN BIOPSY; SKIN EXAMINATION; SKIN TAPE STRIP TECHNIQUE; TH2 CELL; TRANSCRIPTOMICS; TYPE 2 HIGH ATOPIC DERMATITIS; CASE CONTROL STUDY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DEVICES; GENETIC MARKER; GENETIC SCREENING; GENETICS; PROCEDURES; SEQUENCE ANALYSIS; SEVERITY OF ILLNESS INDEX; SURGICAL TAPE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC TESTING; HUMANS; MALE; SEQUENCE ANALYSIS, RNA; SEVERITY OF ILLNESS INDEX; SURGICAL TAPE; TRANSCRIPTOME;

EID: 85041539501     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.10.046     Document Type: Article

References (51)

1. Hanifin, J.M., Reed, M.L., Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermatitis 18 (2007), 82–91.
2. Silverberg, J.I., Simpson, E.L., Associations of childhood eczema severity: a US population-based study. Dermatitis 25 (2014), 107–114.
3. Leung, D.Y., Guttman-Yassky, E., Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 134 (2014), 769–779.
4. Brunner, P.M., Guttman-Yassky, E., Leung, D.Y., The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 139:suppl (2017), S65–S76.
5. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006), 441–446.
6. Weidinger, S., Illig, T., Baurecht, H., Irvine, A.D., Rodriguez, E., Diaz-Lacava, A., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118 (2006), 214–219.
7. Gao, P.S., Rafaels, N.M., Hand, T., Murray, T., Boguniewicz, M., Hata, T., et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 124 (2009), 507–513 e1-7.
8. Paternoster, L., Standl, M., Waage, J., Baurecht, H., Hotze, M., Strachan, D.P., et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 47 (2015), 1449–1456.
9. Gao, P.S., Rafaels, N.M., Mu, D., Hand, T., Murray, T., Boguniewicz, M., et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 125 (2010), 1403–1407.e4.
10. Khattri, S., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., Finney, R., et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol 133 (2014), 1626–1634.
11. Simpson, E.L., Chalmers, J.R., Hanifin, J.M., Thomas, K.S., Cork, M.J., McLean, W.H., et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 134 (2014), 818–823.
12. Elmose, C., Thomsen, S.F., Twin studies of atopic dermatitis: interpretations and applications in the filaggrin era. J Allergy (Cairo), 2015, 2015, 902359.
13. Bieber, T., D'Erme, A.M., Akdis, C.A., Traidl-Hoffmann, C., Lauener, R., Schappi, G., et al. Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go?. J Allergy Clin Immunol 139:suppl (2017), S58–S64.
14. Beck, L.A., Thaci, D., Hamilton, J.D., Graham, N.M., Bieber, T., Rocklin, R., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371 (2014), 130–139.
15. Simpson, E.L., Bieber, T., Guttman-Yassky, E., Beck, L.A., Blauvelt, A., Cork, M.J., et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375 (2016), 2335–2348.
16. Ewald, D.A., Malajian, D., Krueger, J.G., Workman, C.T., Wang, T., Tian, S., et al. Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Med Genomics, 8, 2015, 60.
17. Suarez-Farinas, M., Ungar, B., Correa da Rosa, J., Ewald, D.A., Rozenblit, M., Gonzalez, J., et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol 135 (2015), 1218–1227.
18. Suarez-Farinas, M., Tintle, S.J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127 (2011), 954–964 e1-4.
19. Cole, C., Kroboth, K., Schurch, N.J., Sandilands, A., Sherstnev, A., O'Regan, G.M., et al. Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis. J Allergy Clin Immunol 134 (2014), 82–91.
20. Reynolds, S.D., Rios, C., Wesolowska-Andersen, A., Zhuang, Y., Pinter, M., Happoldt, C., et al. Airway progenitor clone formation is enhanced by Y-27632-dependent changes in the transcriptome. Am J Respir Cell Mol Biol 55 (2016), 323–336.
21. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 15, 2014, 550.
22. Huber, W., Carey, V.J., Gentleman, R., Anders, S., Carlson, M., Carvalho, B.S., et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 12 (2015), 115–121.
23. Chen, E.Y., Tan, C.M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G.V., et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics, 14, 2013, 128.
24. Luo, W., Friedman, M.S., Shedden, K., Hankenson, K.D., Woolf, P.J., GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics, 10, 2009, 161.
25. Subramanian, A., Kuehn, H., Gould, J., Tamayo, P., Mesirov, J.P., GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23 (2007), 3251–3253.
26. Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res 41 (2013), D991–D995.
27. Davis, S., Meltzer, P.S., GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23 (2007), 1846–1847.
28. Szeles, L., Poliska, S., Nagy, G., Szatmari, I., Szanto, A., Pap, A., et al. Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol 24 (2010), 2218–2231.
29. Hutter, C., Kauer, M., Simonitsch-Klupp, I., Jug, G., Schwentner, R., Leitner, J., et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120 (2012), 5199–5208.
30. Poole, A., Urbanek, C., Eng, C., Schageman, J., Jacobson, S., O'Connor, B.P., et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol 133 (2014), 670–678.e12.
31. Thompson, M.D., Capra, V., Clunes, M.T., Rovati, G.E., Stankova, J., Maj, M.C., et al. Cysteinyl leukotrienes pathway genes, atopic asthma and drug response: from population isolates to large genome-wide association studies. Front Pharmacol, 7, 2016, 299.
32. Candi, E., Schmidt, R., Melino, G., The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6 (2005), 328–340.
33. Hirota, T., Takahashi, A., Kubo, M., Tsunoda, T., Tomita, K., Sakashita, M., et al. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet 44 (2012), 1222–1226.
34. Denzin, L.K., Sant'Angelo, D.B., Hammond, C., Surman, M.J., Cresswell, P., Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278 (1997), 106–109.
35. Kraft, S., Kinet, J.P., New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 7 (2007), 365–378.
36. Esaki, H., Ewald, D.A., Ungar, B., Rozenblit, M., Zheng, X., Xu, H., et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol 135 (2015), 153–163.
37. Nomura, I., Gao, B., Boguniewicz, M., Darst, M.A., Travers, J.B., Leung, D.Y., Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112 (2003), 1195–1202.
38. Howell, M.D., Gallo, R.L., Boguniewicz, M., Jones, J.F., Wong, C., Streib, J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006), 341–348.
39. Li, S., Villarreal, M., Stewart, S., Choi, J., Indra, G., Babineau, D.C., et al. Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis. Br J Dermatol 177 (2017), e125–e127.
40. Li, W., Turner, A., Aggarwal, P., Matter, A., Storvick, E., Arnett, D.K., et al. Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis. BMC Genomics, 16, 2015, 1069.
41. Harper, J.I., Godwin, H., Green, A., Wilkes, L.E., Holden, N.J., Moffatt, M., et al. A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis. Br J Dermatol 162 (2010), 397–403.
42. Singh, R.K., Gupta, S., Dastidar, S., Ray, A., Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 85 (2010), 336–349.
43. Liu, M., Yokomizo, T., The role of leukotrienes in allergic diseases. Allergol Int 64 (2015), 17–26.
44. Grill, J.I., Neumann, J., Herbst, A., Ofner, A., Hiltwein, F., Marschall, M.K., et al. Loss of DRO1/CCDC80 results in obesity and promotes adipocyte differentiation. Mol Cell Endocrinol 439 (2017), 286–296.
45. Sasagawa, S., Nishimura, Y., Sawada, H., Zhang, E., Okabe, S., Murakami, S., et al. Comparative transcriptome analysis identifies CCDC80 as a novel gene associated with pulmonary arterial hypertension. Front Pharmacol, 7, 2016, 142.
46. Brunner, P.M., Emerson, R.O., Tipton, C., Garcet, S., Khattri, S., Coats, I., et al. Non-lesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy 72 (2017), 2017–2025.
47. Yoshida, K., Kubo, A., Fujita, H., Yokouchi, M., Ishii, K., Kawasaki, H., et al. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol 134 (2014), 856–864.
48. Bieber, T., Novak, N., Herrmann, N., Koch, S., Role of dendritic cells in atopic dermatitis: an update. Clin Rev Allergy Immunol 41 (2011), 254–258.
49. Guttman-Yassky, E., Lowes, M.A., Fuentes-Duculan, J., Whynot, J., Novitskaya, I., Cardinale, I., et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 119 (2007), 1210–1217.
50. Woodruff, P.G., Modrek, B., Choy, D.F., Jia, G., Abbas, A.R., Ellwanger, A., et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180 (2009), 388–395.
51. Hamilton, J.D., Suarez-Farinas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol 134 (2014), 1293–1300.